IDEAYA Biosciences, Inc.

US$31.24As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:IDYAHealthcare
Country USA
PE (Fwd) •••
TSR 7Y CAGR 13.89%
Div yield —
ROE (38.46%)
Biotechnology
Beta (5Y) 0.08
PE TTM —
TSR TTM (1.95%)
Mkt cap US$3.021B
ROIC (25.83%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$31
0.35%
(85.60%)
Hold 5|11|10|3|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.60
0.60
0.58
0.57
23.43%
13.45%
13.49%
3.94%
Revenue$M
381.9
402.3
404.6
427.8
10.20%
15.84%
11.34%
16.28%
Peers (US$3.021B)
Cap (US$)
PE
2.824B
16.51x
Capital
TTM
5Y
10Y
Leveragex
2.231
7.133
6.756
EBIT/Intx
1.354
0.256
0.220
Own earn%
38.37
321.47
316.10
Sh yield%
50.05
31.00
34.17
Owners
Insiders/Inst%
7.71
64.63
Short interest%
1.59
SBC / revenue%
4.60
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
12–16
$1 testx
0.2
Incr. ROIC%
6